Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Progyny, Inc.

Market Cap 2.09B 1.8B 1.66B 1.56B 2.92B 198B 2.96B 19.68B 7.66B 96.49B 7.83B 7.66B 334B P/E Ratio 2026 *
20.5x
P/E Ratio 2027 * 18x
Enterprise Value 1.92B 1.66B 1.53B 1.43B 2.68B 182B 2.72B 18.1B 7.04B 88.72B 7.2B 7.04B 307B EV / Sales 2026 *
1.39x
EV / Sales 2027 * 1.15x
Free-Float
76.7%
Yield 2026 *
-
Yield 2027 * -
1 day+3.82%
1 week+2.98%
Current month+4.19%
1 month+13.56%
3 months+52.17%
6 months-0.30%
Current year+3.70%
1 week 25.18
Extreme 25.185
26.74
1 month 22.57
Extreme 22.57
26.74
Current year 16.1
Extreme 16.1
28.75
1 year 16.1
Extreme 16.1
28.75
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 2021-12-31
Director of Finance/CFO 60 2020-09-14
Chief Operating Officer 56 2025-04-16
Director TitleAgeSince
Chairman 66 2021-12-31
Director/Board Member 77 2016-12-15
Director/Board Member 58 2021-12-31
Date Insider Type Main position Quantity % Market Cap.
06-03Tax

General Counsel

-938 0.0012%
06-03Tax

Chief Financial Officer

-2,856 0.0036%
06-02Tax

Chief Executive Officer

-5,361 0.0068%
Change 5-day change 1-year change 3-year change Capi.($)
+3.82%+2.98%+23.57%-32.58% 2.09B
+0.73%+2.27%+28.26%-17.07% 371B
+1.23%-2.76%+4.62%-14.55% 87.75B
+1.07%+2.94%-5.51%+11.61% 78.83B
+2.86%+8.32%+61.40%-26.11% 45.53B
+2.60%+4.59%+17.71%-5.77% 32.19B
+3.66%+4.94%-31.76%-30.62% 10.43B
-2.42%+28.50%+30.97%+166.17% 4.08B
-3.47%+23.50%+61.43%+395.18% 2.49B
+7.52%+4.41%-24.94% - 293M
Average +1.76%+8.20%+16.58%+49.59% 63.47B
Weighted average by Cap. +1.11%+2.52%+21.76%-10.71%

Financials

2026 *2027 *
Net sales 1.38B 1.2B 1.1B 1.03B 1.93B 131B 1.96B 13.05B 5.08B 63.95B 5.19B 5.08B 221B 1.5B 1.3B 1.2B 1.12B 2.1B 143B 2.14B 14.2B 5.52B 69.59B 5.65B 5.53B 241B
Net income 109M 94.17M 86.75M 81.25M 152M 10.36B 155M 1.03B 400M 5.04B 409M 400M 17.45B 125M 108M 99.92M 93.59M 176M 11.93B 178M 1.18B 461M 5.8B 471M 461M 20.1B
Net Debt -168M -145M -134M -125M -235M -15.99B -239M -1.59B -617M -7.78B -631M -617M -26.93B -359M -310M -286M -268M -502M -34.14B -510M -3.39B -1.32B -16.61B -1.35B -1.32B -57.51B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
26-06-12 26.63 $ +3.82% 1,313,481
26-06-11 25.65 $ -0.93% 1,200,861
26-06-10 25.89 $ +0.23% 1,122,401
26-06-09 25.83 $ -0.35% 1,588,433
26-06-08 25.92 $ +0.23% 1,612,893
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
26.63USD
Average target price
29.73USD
Spread / Average Target
+11.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGNY Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!